Crispr Therapeutics Ag (CRSP)

Investing Cash Flow

-$55.66M

Quarterly · Period ending: · USD

CRSP logo

CRSP Investing Cash Flow

Latest reported-$55.66M
CRSP Quarterly Cash from Investing ($0.00 → -$55.66M)
High-resolution chart · PNG

CRSP investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-55,659,000
-410,743,000
37,199,000
-119,226,000
69,977,000
-19,755,000
105,828,000
-161,604,000
-126,905,000
-97,800,000
-81,453,000
121,348,000
216,923,000
117,829,000
-175,532,000
87,464,000
-56,072,000
-114,515,000
-8,716,000
-565,180,000
-293,636,000
-167,898,000
-204,244,000
-330,330,000
-3,605,000
-2,991,000
7,057,000
-2,461,000
-2,174,000
-1,097,000
-1,000,000
-695,000
-523,000
-555,000
-205,000
-3,494,000
-1,330,000
-3,285,000
14,772,000
-1,509,000
-1,047,000
19,668,000
-503,000
-549,000
-102,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.